Results 241 to 250 of about 531,165 (296)

Non-Genetically Modified Adoptive Cell Therapies for Solid Tumors: Current Landscape and Future Challenges. [PDF]

Cancer Immunol Immunother
Luo Q, Jiang W, Xie Y, Dai Z, Zhu J, Du Y, Tao X, Lei Z, Chu X, Wang B, Fu G.   +10 more
europepmc   +1 more source

Antitumor antibiotics.

Postepy higieny i medycyny doswiadczalnej, 1974
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Dihydrochalcones as Antitumor Agents

Current Medicinal Chemistry, 2022
Abstract: Dihydrochalcones are a class of secondary metabolites, possessing several biological properties such as antitumor, antioxidant, antibacterial, antidiabetic, estrogenic, anti-inflammatory, antithrombotic, antiviral, neuroprotective, and immunomodulatory properties; therefore, they are currently considered promising candidates in the drug ...
Fabiola De Luca, Carla Di Chio, Maria Zappala', Roberta Ettari   +3 more
openaire   +2 more sources

Antitumor Carbazoles

Anti-Cancer Agents in Medicinal Chemistry, 2007
Natural and synthetic carbazoles, either in a pure substituted or in an annellated substituted form, represent an important and heterogeneous class of anticancer agents, which has grown considerably over the last two decades. Many carbazole derivatives have been tested for cyctotoxic activity, some of them have entered clinical trials, but only ...
Asche, Christian, Demeunynck, Martine
openaire   +2 more sources

An orally available non-nucleotide STING agonist with antitumor activity

Science, 2020
Targeting STING for cancer therapy Activation of the STING (stimulator of interferon genes) protein by cyclic dinucleotide metabolites plays a critical role in antitumor immunity.
B. Pan, Samanthi A. Perera, J. Piesvaux, J. Presland, Gottfried K. Schroeder, J. Cumming, B. Trotter, M. Altman, A. Buevich, B. Cash, S. Cemerski, Wonsuk Chang, Yiping Chen, P. Dandliker, Guo Feng, Andrew M Haidle, T. Henderson, James P. Jewell, I. Kariv, Ian Knemeyer, J. Kopinja, Brian M. Lacey, J. Laskey, C. Lesburg, Rui Liang, B. Long, Min Lu, Yanhong Ma, E. Minnihan, Greg O’Donnell, Ryan Otte, Laura Price, L. Rakhilina, B. Sauvagnat, Sharad K Sharma, S. Tyagarajan, Hyun Woo, D. Wyss, Serena Xu, D. J. Bennett, G. Addona   +40 more
semanticscholar   +1 more source

Antitumor Titanium Compounds

Mini-Reviews in Medicinal Chemistry, 2004
Most anticancer titanium compounds act against tumors in the gastrointestinal tract. Activity towards breast, lung and skin (melanoma) cancers is shown by some as well. Among their appealing properties is that they do not show common side effects of widely used cytostatic agents such as emesis, alopecia or bone marrow impairment.
Caruso Francesco, Rossi Miriam
openaire   +4 more sources